ViiV Healthcare understands this push-and-pull dynamic all too well and sought out to do something about it. “Both sides are waiting for the other person to initiate and take the lead in those deeper ...
For ViiV Healthcare—the HIV-focused joint venture between GSK, Pfizer and Shionogi—the day represents a dual opportunity to both celebrate progress and plan next steps, according to Randevyn ...
Scenes from The Wild Robot, Flow, Inside Out 2, Wallace & Gromit: Vengeance Most Fowl, and Memoir of a Snail are analyzed by ...
London, 31 January 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has ...
Apple TV+ is expanding its kids and families slate with new animated series Goldie, inspired by Emily Brundige’s award-winning 2019 short film of the same name. It’s set for premiere globally ...
A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.
The directors of "Flow," "Inside Out 2," "Memoir of a Snail," "Wallace & Gromit: Vengeance Most Fowl," and "The Wild Robot" analyze the scenes that mattered most. “The Wild Robot,” the Best ...
The Wild Robot—the hit animated movie starring the voice of Lupita Nyong’o—arrives on streaming on Peacock this week. Rated PG, The Wild Robot—which is based on the bestselling children ...
For a while there, it seemed like a crudely drawn webcomic had DreamWorks Animation’s number. In an unflattering contrast to the imaginative movies that Pixar was making in the ‘00s ...
Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...
GlaxoSmithKline' majority-owned HIV unit ViiV has scored a key FDA approval, getting approval for its long-acting drug cabotegravir as the first injectable for pre-exposure prophylaxis (PrEP ...